Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueGross MarginNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Pharming (PHAR) FCF Margin (2020 - 2023)

Historic FCF Margin for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to 32.25%.

  • Pharming's FCF Margin fell 412700.0% to 32.25% in Q2 2023 from the same period last year, while for Mar 2024 it was 10.44%, marking a year-over-year decrease of 104500.0%. This contributed to the annual value of 0.27% for FY2024, which is 3200.0% up from last year.
  • According to the latest figures from Q2 2023, Pharming's FCF Margin is 32.25%, which was down 412700.0% from 1.5% recorded in Q4 2022.
  • Pharming's 5-year FCF Margin high stood at 93.59% for Q1 2022, and its period low was 32.25% during Q2 2023.
  • Its 4-year average for FCF Margin is 9.09%, with a median of 0.09% in 2020.
  • In the last 5 years, Pharming's FCF Margin skyrocketed by 935900bps in 2022 and then tumbled by -412700bps in 2023.
  • Pharming's FCF Margin (Quarter) stood at 0.09% in 2020, then crashed by -47bps to 0.05% in 2021, then soared by 2876bps to 1.5% in 2022, then crashed by -2255bps to 32.25% in 2023.
  • Its FCF Margin stands at 32.25% for Q2 2023, versus 1.5% for Q4 2022 and 9.81% for Q3 2022.